Enzima Pharmaceuticals
Enzima Pharmaceuticals is a for-profit social enterprise transforming disease therapy and business in West Nile, Dengue, and Yellow Fever treatment
| Startup type: | Social Enterprise |
| Status: | Active |
| Stage: | Prototyping |
| Publicity: | Open to speaking to journalists. |
| Industries: | Biotech, Health |
| Location: | Palo Alto, CA |
OUR NEWS
Enzima Pharmaceuticals has no news yet.
ABOUT US
Enzima is a for-profit social enterprise intent on transforming disease therapy & business.
We plan to offer a cost-effective drug treatment for West Nile, dengue, and yellow fever – debilitating developing world diseases. We have a novel drug discovery platform that can identify a single drug for all 3 diseases, while limiting the possibility of drug resistance.
Our social enterprise model, in turn, reduces our costs and expedites our services. We can utilize global partnerships to gain exclusive market rights and subsidized drug therapy for afflicted patients in the developing world. Enzima thus offers a sustainable business practice that serves both patient and investor interests to significant returns on investment.
THINGS WE NEED
The Enzima Pharmaceuticals team hasn't posted any needs yet.
COMMENTS (0)
Team (3)
View all-
Bilal Mahmood
Business Operations professional. Former Policy Analyst at US Department of Commerce and Co-Founder at Gumball Capital. Stanford Undergrad and Gates Scholar at University of Cambridge.
-
-
Michael Vellat
MSc in Information Systems and Management from University of Warwick (2008) Pursuing MPhil in Bioscience Enterprise from University of Cambridge. Part of CEO Team at Mondobiotech (2008-2009), also worked in PRTM Management Consulting 08 & UBS SA 05.